UCB’s Vimpat NDA Seeks Indications For Epileptic Seizures, Diabetic Pain
This article was originally published in The Pink Sheet Daily
Executive Summary
Belgian firm has an anticipated July 2008 user fee date for lacosamide, which was submitted as a single NDA with two indications, for partial onset seizures in epilepsy and diabetic neuropathic pain.